Richard R. Neubig

Richard Neubig is currently a Professor of Pharmacology & Toxicology at Michigan State University and the Director of MSU Drug Discovery. Richard also serves as the President of FibrosIX Inc., a start-up focused on developing novel antifibrotic agents. Throughout their career, Richard has held various leadership roles in organizations such as NC-IUPHAR and ASPET. Richard previously worked at the University of Michigan as a Professor and Co-Director of the Center for Chemical Genomics. Richard holds an MD-PhD from Harvard Medical School and a BS in Chemistry from the University of Michigan.